HPV and beyond-looking out for biomarkers for distinguishing the good prognosis from the bad prognosis group in locally advanced and clinically high risk HNSCC
Ann Transl Med. 2015 Oct;3(17):255.
doi: 10.3978/j.issn.2305-5839.2015.09.35.
1 1 German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) partner site Dresden, Dresden, Germany ; 2 Department of Radiation Oncology, 3 OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität, Dresden, Germany ; 4 Institute of Radiooncology, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany.